Patents by Inventor Rhys Allan

Rhys Allan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
    Publication number: 20220331332
    Abstract: The present invention relates to methods and pharmaceutical composition for the treatment of T-helper type 2 (Th2)-mediated diseases. More particularly, the present invention relates to an inhibitor of the Suv39h1-HP1a silencing pathway for use in the treatment of a T-helper type 2 (Th2)-mediated disease, in particular allergic asthma.
    Type: Application
    Filed: May 6, 2022
    Publication date: October 20, 2022
    Inventors: Sebastian AMIGORENA, Rhys ALLAN, Heidi SCHREIBER, Elina ZUEVA, Genevieve ALMOUSNI
  • Methods of Treating Inflammation
    Publication number: 20220016111
    Abstract: Methods for treating inflammation, including allergic inflammation, lymphocyte-driven inflammation, and inflammatory conditions such as allergic asthma and allergic lung inflammation, using inhibitors of the polycomb repressive complex 2 (PRC2) methyltransferase enhancer of zeste homolog 2 (Ezh2) are provided.
    Type: Application
    Filed: December 17, 2019
    Publication date: January 20, 2022
    Inventors: Rhys Allan, Christine Keenan, Stephan Nutt
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
    Publication number: 20190117664
    Abstract: The present invention relates to methods and pharmaceutical composition for the treatment of T-helper type 2 (Th2)-mediated diseases. More particularly, the present invention relates to an inhibitor of the Suv39h1-HP1a silencing pathway for use in the treatment of a T-helper type 2 (Th2)-mediated disease, in particular allergic asthma.
    Type: Application
    Filed: December 7, 2018
    Publication date: April 25, 2019
    Inventors: Sebastian AMIGORENA, Rhys ALLAN, Heidi SCHREIBER, Elina ZUEVA, Genevieve ALMOUZNI
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
    Publication number: 20150038496
    Abstract: The present invention relates to methods and pharmaceutical composition for the treatment of T-helper type 2 (Th2)-mediated diseases. More particularly, the present invention relates to an inhibitor of the Suv39h1-HP1a silencing pathway for use in the treatment of a T-helper type 2 (Th2)-mediated disease, in particular allergic asthma.
    Type: Application
    Filed: October 3, 2012
    Publication date: February 5, 2015
    Inventors: Sebastian Amigorena, Rhys Allan, Heidi Schreiber, Elina Zueva, Genevieve Almouzni